AIForbes Innovation3 days ago
SpaceX's Healthcare Plays
1 min read
SpaceX's SEC filing reveals healthcare ambitions beyond Starlink's 10 million subscribers enabling remote care in underserved areas. The company told investors it wants to manufacture pharmaceuticals in orbit, citing microgravity benefits for drug solubility and stability. SpaceX reported $18.7 billion in revenue last year with a $4.9 billion net loss.
Level
Hype check
Tap to vote and see what everyone thinks.
